Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model
Tao Yin(Wuhan Union Hospital), Yongsheng Wang(Guangzhou University of Chinese Medicine)
Cited by 53
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway
|Journal of Experimental & Clinical Cancer Research|2019|96
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
|Nature Communications|2018|35
Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
|Frontiers in Oncology|2021|31
Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3
|International Journal of Oncology|2015|27